Bayer writes a loss of almost three billion euros. CEO Anderson is sticking to the group structure, including the weak agricultural division.
Bayer wants to pursue ‘new approaches inside and outside the courtrooms’ The background is a wave of lawsuits because of the alleged carcinogenic effects of Glypharicide. For 2024, Bayer expects sales of 47 billion to 49 billion euros and an Ebitda of 10.7 billion to 11.3 billion euros, according to its annual report.